Category Archives: Articles

Premenstrual disorders (PMDs) comprise physical and mood-related symptoms that occur repeatedly in association with the premenstrual phase of the female reproductive cycle. Though they are known to reduce the quality of life of affected women and are linked to a higher risk of suicidal thoughts and intentions and hypertension, not much else is known about […]

TOPLINE: Alcohol exclusion laws (AELs) that allow health insurers to deny coverage of injuries sustained while individuals are intoxicated remain on the books in 18 states, despite evidence showing that these laws prevent people from receiving treatment for alcohol use disorder. METHODOLOGY: Systematic legal analysis using the Alcohol Policy Information System to identify states in […]

In a recent article published in Jama Network Open, researchers estimated the association between receipt of BNT162b2 vaccine and coronavirus disease 2019 (COVID-19)-related ambulatory visits in United States (US) children below the age of five years. Study: Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years. Image Credit: Ground Picture/Shutterstock.com Background In the […]

You know that eerie moment when you’re halfway through an article or ad and you realize – “Hold on a second, a human didn’t write this. An AI did!”? We’ve all been there. It’s a bit like biting into a juicy apple, only to realize it’s made of plastic.  Sure, we’ve got AI now – […]

A newly published scientific statement from the American Heart Association (AHA) focuses on the impact of aggressive low-density lipoprotein cholesterol (LDL-C) lowering on the risk for dementia and hemorrhagic stroke. “The brain is the body’s most cholesterol-rich organ, and some have questioned whether aggressive LDL-C lowering induces abnormal structural and functional changes,” the writing group, […]

Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors […]

The first randomized trial to evaluate postprocedural anticoagulation (PPA) in patients undergoing a primary percutaneous coronary intervention (PCI) for an ST-segment elevation myocardial infarction (STEMI) did not associate significant benefit — or significant harm — with any of the three tested regimens relative to placebo. There has been a signal from nonrandomized studies that PPA […]

You are what you eat, according to the adage. But it’s not just the body that’s impacted. According to research from UCLA David Geffen School of Medicine, living in a disadvantaged neighborhood can affect food choices, weight gain and even the microstructure of the brain. The study, appearing in Communications Medicine, a Nature journal, finds […]

The US Food and Drug Administration (FDA) today approved the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis patients with anemia, according to a press release from maker GSK. Momelotinib is the fourth JAK inhibitor to be approved by the agency for myelofibrosis but the only one indicated for patients with hemoglobin levels below 10 g/dL. It’s […]

A new Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration of dopaminergic neurons is widely accepted as the first event that leads to Parkinson’s. But the new study suggests that a dysfunction in the neuron’s synapses -; the tiny gap across which a neuron can send an impulse to another […]